Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.
Rosenkranz M. et al, (2024), Life Sci Alliance, 7
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.
Nkumama IN. et al, (2024), Immunity, 57, 1215 - 1224.e6
Antibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria Transmission.
Mutemi DD. et al, (2024), Vaccines (Basel), 12
Integrating vaccines and monoclonal antibodies into malaria prevention.
Taylor TE. and Osier F., (2024), Nat Med
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Odera DO. et al, (2023), Sci Transl Med, 15
Characterization of a novel Plasmodium falciparum merozoite surface antigen and potential vaccine target.
Niaré K. et al, (2023), Front Immunol, 14
Malaria attributable fractions with changing transmission intensity: Bayesian latent class vs logistic models.
Mwai K. et al, (2022), Malar J, 21
Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.
Fernandez N. et al, (2022), Front Immunol, 13
The effect of malaria on childhood anemia in a quasi-experimental study of 7,384 twins from 23 Sub-Saharan African countries.
Starck T. et al, (2022), Front Public Health, 10